Navigation Links
Metabolix Executives to Present at Leading Industry Conferences
Date:6/10/2013

CAMBRIDGE, Mass., June 10, 2013 /PRNewswire/ -- Metabolix, Inc. (NASDAQ: MBLX), an innovation-driven bioscience company focused on delivering sustainable solutions for plastics, chemicals and energy, today announced that its executives will be presenting at two leading industry conferences in June. Metabolix President and Chief Executive Officer Richard P. Eno will discuss trends in the biopolymers industry at Smithers Rapra's Biopolymers Symposium 2013 on June 11, and he will moderate a panel at the Biotechnology Industry Organization's (BIO) 10th Annual World Congress on Industrial Biotechnology on June 19. In addition, Max Senechal, Metabolix's vice president of biobased chemicals, will discuss commercialization strategies for renewable chemicals at BIO World Congress on June 17.

(Logo: http://photos.prnewswire.com/prnh/20130607/NE28327LOGO-b)

At the Biopolymers Symposium, Mr. Eno will participate in a panel discussion with executives from NatureWorks and Virent. The session will focus on the future of biopolymers, and Mr. Eno will address Metabolix's experience working with customers to achieve commercial success.

At the BIO World Congress on Industrial Biotechnology, Mr. Senechal will participate in the "Renewable Chemicals through Strain Engineering and Process Optimization" panel discussion. Executives and researchers from Green Biologics, zuChem, PRAJ-Matrix and the University of Illinois will also be part of the session. Separately, Mr. Eno will be moderating the "Biomanufacturing at Commercial Scale" panel discussion on commercializing renewable chemicals with executives from Genomatica, Myriant, Clariant and Ajinomoto. Smithers Rapra's Biopolymers Symposium 2013What:"The Future of Biopolymers" panel discussionWho:Richard Eno, president and CEO, MetabolixWhen:Tuesday, June 11, 2013 from 8:40-9:40 a.m. Where: The Field Museum1400 S Lake Shore DriveChicago, IL, 60605 BIO's 10th Annual World Congress on Industrial BiotechnologyWhat:"Renewable Chemicals through Strain Engineering and Process Optimization" and "Biomanufacturing at Commercial Scale" panel discussionsWho:Max Senechal, vice president of biobased chemicals, and Richard Eno, president and CEO, MetabolixWhen:Monday, June 17 from 8:30-10 a.m. (Senechal) and Wednesday, June 19 from 8-10 a.m. (Eno)Where: Palais des congres de Montreal159 Saint-Antoine West, 9th floorMontreal (Quebec) H2Z 1H2, CanadaAbout Metabolix Metabolix, Inc. is an innovation-driven bioscience company delivering sustainable solutions to the plastics, chemicals and energy industries. Metabolix is developing and commercializing a family of high-performance biopolymers targeted to the markets for film and bag applications, performance additives and functional biodegradation. Metabolix's biobased chemicals platform utilizes its novel "FAST" recovery process to enable the production of cost-effective, alternative replacements for petroleum-based industrial chemicals. Metabolix is also developing a platform for co-producing plastics, chemicals and energy from crops. Metabolix has established an industry-leading intellectual property portfolio that, together with its knowledge of advanced industrial practice, provides a foundation for industry collaborations.

For more information, please visit www.metabolix.com. (MBLX-G)

 


'/>"/>
SOURCE Metabolix, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. GDS International Combines Top Healthcare Executives in the United States for its 10th Anniversary NG Healthcare Summit in May
2. GDS International Confirms the Attendance of Top Executives to its Eleventh North American Healthcare Summit in December
3. Lucas Bagnell Varga LLC Secures $17.4 Million Award For Former Applied Biosystems Executives
4. OpenClinica to Exhibit at SCOPE (Summit for Clinical Ops Executives)
5. Aratana Therapeutics Adds Product Manufacturing Expertise with the Appointment of Two Senior Executives
6. Industry Executives to Explore the Future of Life Sciences Research Powered By Big Data Analytics
7. Executives from Johnson & Johnson, GlaxoSmithKline and California State Board of Pharmacy discuss pharmaceutical packaging challenges at Pharmapack North America 2013
8. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
9. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
10. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
11. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... OXFORD, England , Aug. 16, 2017  Kingfisher Talent, ... search and leadership development, and Virdis Group, global executive search ... exclusive alliance that enables clients to leverage the expertise and ... "For our clients here in the Boston ... diverse population of leadership talent throughout the US, ...
(Date:8/15/2017)... ... August 15, 2017 , ... Pittcon is pleased to ... and scientific instruments. This year’s symposium, organized by the Pittcon 2018 program chair, ... Bioanalytical Applications.” This dynamic presentation will discuss novel ionization processes, high throughput IMS-MS ...
(Date:8/15/2017)... Linda, Ca (PRWEB) , ... August 15, 2017 ... ... coffee production and is threatened by various biotic and abiotic factors. During this ... complex evolutionary history of coffee, as well as gain a better understanding of ...
(Date:8/14/2017)... ... 14, 2017 , ... The Conference Forum has confirmed the one-day ... on September 6, 2017 at the Marriott Copley Place in Boston, MA. , Returning ... and Regulatory Strategy, Pfizer Innovative Research Lab, Pfizer, who leads 19 industry speakers in ...
Breaking Biology Technology:
(Date:4/4/2017)... , April 4, 2017   EyeLock LLC , ... that the United States Patent and Trademark Office (USPTO) ... covers the linking of an iris image with a ... and represents the company,s 45 th issued patent. ... is very timely given the multi-modal biometric capabilities that ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and ... 2022", published by MarketsandMarkets, the market is expected to be worth USD 18.98 ... Continue Reading ... ...      ...
Breaking Biology News(10 mins):